The Use of -omic Technologies for Biomarker Development Michael Pfaffl, Principal Investigator, Technical University of Munich, speaking at Genomics Research Asia 2012
Immunogenicity Assessment for the Successful Development of Biosimilars Dr Michael Tovey, Institut Andre Lwoff/INSERM, speaking at Stem Cells & Bioprocessing 2012.
Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity Dr Vanessa Baeriswyl, EPFL, speaking at Stem Cells & Bioprocessing Europe 2012.
Drug-induced Hepatotoxicity Prediction Using Three-Dimensional Culture Models in High Content Screening Context Dr Thierry Dorval, Institut Pasteur Korea, speaking at European Laboratory Automation 2012.
Novel, Simple Technology for Creating Physiologically Relevant 3-D Tissue Models Rosemary Drake, TAP Biosystems, speaking at European Laboratory Automation 2012.
An Integrated System Using Peptide Arrays to Assess Kinase and Nuclear Receptor Activities in Clinical Samples for Biomarker Development Bertrand Jordan, Aix-Marseille University, speaking at Microarray World Congress 2012
Phenotypic Drug Screening: the Power of High Capacity Flow Dr Kim Luu, Intellicyt, Inc., speaking at European Laboratory Automation 2012.
Joint Talk - Deciphering the Cell with GE Healthcare Cell Technologies / The Importance of High Content Analysis for Stem Cell Culture, Differentiation and Media Development Dr. Bergendahl, Miltenyi Biotec GmbH, speaking at European Laboratory Automation 2012.
Actin' Out, Development of a High Content Screen Protocol for Investigation of the Interplay Between Epithelial Junctions and the Actin Cytoskeleton Dr Ann Wheeler, Queen Mary University of London, speaking at European Laboratory Automation 2012.